Oxfendazole
calfenovet
Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Unifendox
universal pharmaceutical industries (unipharma)
TRICLABENDAZOLE 12.000 gm/100ml ; Oxfendazole 4.500 gm/100ml ;
Unifendazole
universal pharmaceutical industries (unipharma)
Oxfendazole 22.500 gm/100ml ;
Ultramox
The Egyptian European Company for import and export
MOXIDECTIN 8.4 gm/1kg ; PRAZIQUANTEL 51 gm/1kg ; Oxfendazole 204 gm/1kg ;
Tricolofen
Badr Pharma for Pharmaceutical Industries -Egypt
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Triclazoleswede
pharma swede - egypt
Oxfendazole 45.3 mg/ml ; TRICLABENDAZOLE 120 mg/ml ; SELENIUM 1 mg/ml ;
Paratrinty
Trinity
Oxfendazole 2.5 gm/100ml ; CLOSANTEL 5 gm/100ml ;
Oxfenswede Plus
pharma swede - egypt
Oxfendazole 25 mg/ml ; CLOSANTEL 50 mg/ml ;
Oxfenswede
pharma swede - egypt
Oxfendazole 90.6 mg/ml ;
Otsel
Martiros for pharmaceutical industries
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ; SELENIUM 1 gm/l ;
Nufendazole
D.B.K FOR PHARMACEUTICAL INDUSTRIES
Oxfendazole 90.6 mg/ml ;
Hebatone
Cavalier Group Pharma
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Fendazomart
Martiros for pharmaceutical industries
Oxfendazole 90.6 gm/l ;
Fenazole suspension
United biomed for pharmaceutical and biological industries
Oxfendazole 22.65 mg/ml ;
Evtric
E.V.C
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Cortada
alboraq for trading and importing
TRICLABENDAZOLE 120 gm/l ; Oxfendazole 45.3 gm/l ;
Biotricloxazole
Biophar Egypt
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Anthicomb
The Tenth of Ramadan for Pharmaceutical Industries & Diagnostic Reagents "RAMEDA"
Oxfendazole 25 mg/ml ; CLOSANTEL 50 mg/ml ;
Amcotricomed
Amcomed for Pharmaceutical and Chemical Industries
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Actifasciol
Actipharm
Oxfendazole 45.3 gm/l ; TRICLABENDAZOLE 120 gm/l ;
Join Our Newsletter
Stay updated with the latest medicines, new companies, and price updates as soon as they are published.
